Evan’s syndrome secondary to COVID-19 infection
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223673Keywords:
Evan’s syndrome, COVID-19 infection, Thrombocytopenia, Autoimmune hemolytic anemiaAbstract
Wide range of autoimmune diseases are known to occur following SARS-CoV-2 infection. There are very few case reports of Evan’s syndrome secondary to COVID-19. We hereby report a case of Evan’s syndrome secondary to COVID-19 infection and discuss its management.
Metrics
References
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470-3.
Mehra NK. Mosaic of autoimmunity: The novel factors of autoimmune diseases. Indian J Med Res. 2020;151(6):615-7.
Gazzaruso C, Carlo SN, Mariani G. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol. 2020;39:2095-7.
Monica L. “Evans syndrome in a patient with COVID-19. Bri J Haematol. 2020;190(2):e59-61.
Cañas, Carlos A. “The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Medical hypotheses. 2020;145:110345.
Bhattacharjee S, Mainak B. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN comprehensive Clin Med. 2020;1-11.
Lazarian G. Autoimmune haemolytic anaemia associated with COVID-19 infection. Bri J Haematol. 2020;190(2):29-31.
Norton A, Roberts I. Management of Evans syndrome. Br J Haematol. 2006;132(2):125-37.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-207.
Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med. 2018;9:171-84.